Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis

One of the target drugs for plaque psoriasis treatment is apremilast, which is a selective phosphodiesterase 4 (PDE4) inhibitor. In this study, 34 moderate-to-severe and severe plaque psoriasis patients from Russia were treated with apremilast for 26 weeks. This allowed us to observe the effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbenko, Dmitry A., Karamova, Arfenya E., Artamonova, Olga G., Deryabin, Dmitry G., Rakitko, Alexander, Chernitsov, Alexandr, Krasnenko, Anna, Elmuratov, Artem, Solomka, Victoria S., Kubanov, Alexey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823747/
https://www.ncbi.nlm.nih.gov/pubmed/33383665
http://dx.doi.org/10.3390/jpm11010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823747/
https://www.ncbi.nlm.nih.gov/pubmed/33383665
http://dx.doi.org/10.3390/jpm11010020

Ejemplares similares